Primary Objective: Dose Parameters and Number of Lymph Nodes Excised and Detected
| Molecular imaging agent | ||||||||
| Study no. | Tilmanocept (nmol) | 68Ga (MBq) | 99mTc (MBq) | IRDye800CW dye (nmol) | Time between administration and SLN mapping (h) | No. of SLNs visualized by the endoscopic camera (n) | Lymph nodes excised (n) | No. of SLNs detected ex vivo by γ-counting* (n) |
| One | 1.5 | 5.5 | 8.1 | 2.25 | 38 | 2 | 12 | 2 |
| Two | 1.5 | 4.4 | 7.4 | 2.25 | 36 | 1 | 12 | 1 |
| Three | 1.5 | 2.9 | 8.9 | 2.25 | 32 | 2 | 12 | 2 |
↵* Using 10% rule based on 99mTc radioactivity in cpm.